Cardiac myosin-binding protein C and hypertrophic cardiomyopathy

Trends in Cardiovascular Medicine

Volumn 8, Issue 4, 1998, Pages 151-157

  Carrier, Lucie ^a   Bonne, Gisèle ^a   Schwartz, Ketty ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MYOSIN BINDING PROTEIN C; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; CHROMOSOME 11P; HEART WORK; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR BIOLOGY; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; RNA SEQUENCE; SARCOMERE;

EID: 0032076651     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00144-8     Document Type: Review

References (51)

1. Beall C, Sepanski MA, Fyrberg EA Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles. Genes Dev. 3:1989;131-140.
2. Bonne G, Carrier L, Bercovici Jet al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 11:1995;438-440.
3. Bronson S, Plaehn E, Kluckman Ket al. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA. 93:1996;9067-9072.
4. Carrier L, Hengstenberg C, Beckmann JSet al. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet. 4:1993;311-313.
5. Carrier L, Bonne G, Bährend Eet al. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res. 80:1997;427-434.
6. Fonknechten N, Chelly J, Lepercq Jet al. CFTR illegitimate transcription in lymphoid cells: quantification and applications to the investigation of pathological transcripts. Hum Genet. 88:1992;508-512.
7. Freiburg A, Gautel M A molecular map of the interactions between titin and myosin-binding protein C: implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem. 235:1996;317-326.
8. Fulton AB, L'Ecuyer T Cotranslational assembly of some cytoskeletal proteins: implications and prospects. J Cell Sci. 105:1993;867-871.
9. Fürst DO, Gautel M The anatomy of a molecular giant: how the sarcomere cytoskeleton is assembled from immunoglobulin superfamily molecules. J Mol Cell Cardiol. 27:1995;951-959.
10. Fürst DO, Vinkemeyer U, Weber K Mammalian skeletal muscle C-protein: purification from bovine muscle, binding to titin and the characterization of a full-length cDNA. J Cell Sci. 102:1992;769-778.
11. Fyrberg E, Fyrberg CC, Beall Cet al. Drosophila melanogaster troponin-T mutations engender three distinct syndromes of myofibrillar abnormalities. J Mol Biol. 216:1990;657-675.
12. Gautel M, Zuffardi O, Freiburg Aet al. Phosphorylation switches specific for the cardiac isoform of myosin binding protein C: a modulator of cardiac contraction? EMBO J. 14:1995;1952-1960.
13. Geisterfer-Lowrance AAT, Christe M, Conner DAet al. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:1996;731-734.
14. Gilbert R, Kelly MG, Mikawa Tet al. The carboxyl terminus of myosin binding protein C (MyBP-C, C protein) specifies incorporation into A-band of striated muscle. J Cell Sci. 109:1996;101-111.
15. Hartzell HC Effects of phosphorylation and unphosphorylated C-protein on cardiac actomyosin ATPase. J Mol Biol. 186:1985;185-195.
16. 2+-calmodulin-dependent protein kinases. J Biol Chem 259:15,587-15,596.
17. Hartzell HC, Titus L Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle. J Biol Chem. 257:1982;2111-2120.
18. 2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol. 97:1991;1141-1163.
19. Jeacocke S, England P Phosphorylation of a myofibrillar protein of Mr 150,000 in perfused rat heart, and the tentative identification of this as C-protein. FEBS Lett. 122:1980;129-132.
20. Kimura A, Harada H, Park JEet al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet. 16:1997;379-382.
21. Kolmerer B, Olivieri N, Witt CCet al. Genomic organization of M line titin and its tissue-specific expression in two distinct isoforms. J Mol Biol. 256:1996;556-563.
22. Koretz JF, Coluccio LM, Bertasso AM The aggregation characteristics of column-purified rabbit skeletal myosin in the presence and absence of C-protein at pH 7.0. Biophys J. 37:1982;433-440.
23. Koshida S, Kurasawa M, Yasuda Met al. Assembly of cardiac C-protein during myofibrillogenesis in myogenic cells in culture. Cell Struct Funct. 20:1995;253-261.
24. Labeit S, Gautel M, Lakey Aet al. Towards a molecular understanding of titin. EMBO J. 11:1992;1711-1716.
25. Marian AJ, Roberts R Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation. 92:1995;1336-1347.
26. Marian AJ, Yu QT, Mann DLet al. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res. 77:1995;98-106.
27. Marian AJ, Zhao G, Seta Yet al. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ Res. 81:1997;76-85.
28. Maron BJ, Gardin JM, Flack JMet al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 92:1995;785-789.
29. Moos C, Feng INM Effect of C-Protein on actomyosin ATPase. Biochim Biophys Acta. 632:1980;141-149.
30. Moos C, Offer G, Starr Ret al. Interaction of C-protein with myosin, myosin rod and light meromyosin. J Mol Biol. 97:1975;1-9.
31. Moos C, Mason CM, Besterman JMet al. The binding of skeletal muscle C-protein to F-actin, and its relation to the interaction of actin with myosin subfragment-1. J Mol Biol. 124:1978;571-586.
32. Musacchio A, Saraste M, Wilmanns M High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat Struct Biol. 1:1994;546-551.
33. Offer G, Moos C, Starr R A new protein of the thick filaments of vertebrate skeletal myofibrils: extraction, purification and characterization. J Mol Biol. 74:1973;653-676.
34. Okagaki T, Weber FE, Fischman DAet al. The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J Cell Biol. 123:1993;619-626.
35. Poetter K, Jiang H, Hassanzadeh Set al. Mutation in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 13:1996;63-69.
36. Reinach FC, Masaki T, Shafiq Set al. Isoforms of C-protein in adult chicken skeletal muscle: detection with monoclonal antibodies. J Cell Biol. 95:1982;78-84.
37. Rottbauer W, Gautel M, Zehelein Jet al. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy: characterization of cardiac transcript and protein. J Clin Invest. 100:1997;475-482.
38. Schlender KK, Bean LJ Phosphorylation of chicken cardiac C-protein by calcium/calmodulin-dependent protein kinase II. J Biol Chem. 266:1991;2811-2817.
39. Schwartz K, Carrier L, Guicheney Pet al. The molecular basis of cardiomyopathies. Circulation. 91:1995;532-540.
40. Seiler SH, Fischman DA, Leinwand LA Modulation of myosin filament organization by C-protein family members. Mol Biol Cell. 7:1996;113-127.
41. Starr R, Offer G Polypeptide chains of intermediate molecular weight in myosin preparations. FEBS Lett. 15:1971;40-44.
42. Starr R, Offer G The interaction of C-protein with heavy meromyosin and subfragment-2. Biochem J. 171:1978;813-816.
43. Sweeney HL, Straceski AJ, Leinwand LAet al. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem. 269:1994;1603-1605.
44. Tanaka K, Tamura T, Yoshimura Tet al. Proteasomes: protein and gene structures. New Biol. 4:1992;173-187.
45. Vikstrom KL, Leinwand LA Contractile protein mutations and heart disease. Curr Opin Cell Biol. 8:1996;97-105.
46. Vikstrom KL, Factor SM, Leinwand LA Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med. 2:1996;556-567.
47. Watkins H, Conner D, Thierfelder Let al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 11:1995;434-437.
48. Watkins H, Seidman JG, Seidman CE Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet. 4:1995;1721-1727.
49. Watkins H, Seidman CE, Seidman JGet al. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. J Clin Invest. 98:1996;2456-2461.
50. Weisberg A, Winegrad S Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci USA. 93:1996;8999-9003.
51. Yu B, French JA, Carrier Let al. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the myosin binding protein C gene. J Med Genet. 35:1998;205-210.